Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexanian

Showing results (71-80 of 371) with videos related to

Pageof 38
Sort By:
The New England Journal of Medicine|May 24, 1984
Effective treatment of advanced multiple myeloma refractory to alkylating agentsB Barlogie, L Smith, R Alexanian
Accounts of Chemical Research|March 26, 2019
Transition-Metal (Pd, Ni, Mn)-Catalyzed C-C Bond Constructions Involving Unactivated Alkyl Halides and Fundamental Synthetic Building BlocksMegan R Kwiatkowski, Erik J Alexanian
Journal of the American Chemical Society|October 29, 2008
Mechanistic study of beta-hydrogen elimination from organoplatinum(II) enolate complexesErik J Alexanian, John F Hartwig
Analytical and Quantitative Cytology and Histology|May 1, 1987
Characterization of hematologic malignancies by flow cytometryB Barlogie, P McLaughlin, R Alexanian
Chemical Science|November 2, 2022
Heteroarylation of unactivated C-H bonds suitable for late-stage functionalizationAustin S Miller, Erik J Alexanian
Angewandte Chemie (International Ed. in English)|May 16, 2019
Cobalt-Catalyzed Aminocarbonylation of Alkyl Tosylates: Stereospecific Synthesis of AmidesBrendon T Sargent, Erik J Alexanian
The American Journal of Medicine|May 1, 1986
Biclonal and hypodiploid multiple myelomaL Smith, B Barlogie, R Alexanian
Annals of Internal Medicine|July 1, 1986
High-dose glucocorticoid treatment of resistant myelomaR Alexanian, B Barlogie, D Dixon
Southern Medical Journal|December 1, 1984
Connective tissue disease manifested as multiple myelomaC J Tula, L Berman, R Alexanian
Organic Letters|August 12, 2017
Cobalt-Catalyzed Silylcarbonylation of Unactivated Secondary Alkyl Tosylates at Low PressureJoan E Roque Peña, Erik J Alexanian
Pageof 38

Showing results (71-80 of 371) with videos related to

Sort By:
Pageof 38
The New England Journal of Medicine|May 24, 1984
Effective treatment of advanced multiple myeloma refractory to alkylating agentsB Barlogie, L Smith, R Alexanian
Accounts of Chemical Research|March 26, 2019
Transition-Metal (Pd, Ni, Mn)-Catalyzed C-C Bond Constructions Involving Unactivated Alkyl Halides and Fundamental Synthetic Building BlocksMegan R Kwiatkowski, Erik J Alexanian
Journal of the American Chemical Society|October 29, 2008
Mechanistic study of beta-hydrogen elimination from organoplatinum(II) enolate complexesErik J Alexanian, John F Hartwig
Analytical and Quantitative Cytology and Histology|May 1, 1987
Characterization of hematologic malignancies by flow cytometryB Barlogie, P McLaughlin, R Alexanian
Chemical Science|November 2, 2022
Heteroarylation of unactivated C-H bonds suitable for late-stage functionalizationAustin S Miller, Erik J Alexanian
Angewandte Chemie (International Ed. in English)|May 16, 2019
Cobalt-Catalyzed Aminocarbonylation of Alkyl Tosylates: Stereospecific Synthesis of AmidesBrendon T Sargent, Erik J Alexanian
The American Journal of Medicine|May 1, 1986
Biclonal and hypodiploid multiple myelomaL Smith, B Barlogie, R Alexanian
Annals of Internal Medicine|July 1, 1986
High-dose glucocorticoid treatment of resistant myelomaR Alexanian, B Barlogie, D Dixon
Southern Medical Journal|December 1, 1984
Connective tissue disease manifested as multiple myelomaC J Tula, L Berman, R Alexanian
Organic Letters|August 12, 2017
Cobalt-Catalyzed Silylcarbonylation of Unactivated Secondary Alkyl Tosylates at Low PressureJoan E Roque Peña, Erik J Alexanian
Pageof 38